Intra-Cellular Therapies Inc (NASDAQ:ITCI)
| 23.71 BATS BZX Real-Time Price As of 1:38pm ET |  +0.87 / +3.81%Today’s Change | 6.75 Today|||52-Week Range 43.56 | -30.89% Year-to-Date |
Latest ITCI News | Press Releases
No recent news for Intra-Cellular Therapies Inc.
Today’s Trading
| Previous close | 22.84 |
| Today’s open | 23.19 |
| Day’s range | 23.05 - 23.71 |
| Volume | 399,733 |
| Average volume (3 months) | 2,230,309 |
| Market cap | $1.5B |
Data as of 1:38pm ET, 02/18/2020
Growth & Valuation
| Earnings growth (last year) | -33.75% |
| Earnings growth (this year) | +2.90% |
| Earnings growth (next 5 years) | +2.50% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.95 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMRXAmneal Pharmaceutica... | -0.20 | -4.07% |
| CORTCorcept Therapeutics... | +0.40 | +3.00% |
| INVAInnoviva Inc | -0.10 | -0.66% |
| CNSTConstellation Pharma... | +1.80 | +4.99% |
Data as of 1:39pm ET, 02/18/2020
Financials
| Next reporting date | February 25, 2020 |
| EPS forecast (this quarter) | -$0.81 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$155.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
